NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
3.430
+0.080 (2.39%)
Nov 22, 2024, 4:00 PM EST - Market closed
NLS Pharmaceutics AG Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 19 | 43 | 16 | - | - | |
| Market Cap Growth | -99.40% | -55.33% | 161.62% | - | - | - | |
| Enterprise Value | 8 | 17 | 42 | 9 | - | - | |
| Last Close Price | 3.43 | 23.60 | 51.60 | 44.40 | - | - | |
| PB Ratio | -0.02 | -2.17 | 13.05 | 30.18 | - | - | |
| P/TBV Ratio | - | - | 13.05 | 30.18 | - | - | |
| Debt / Equity Ratio | -0.18 | -0.18 | - | - | -0.23 | -0.14 | |
| Quick Ratio | 0.08 | 0.12 | 2.68 | 2.28 | 0.02 | 0.08 | |
| Current Ratio | 0.15 | 0.23 | 2.75 | 2.38 | 0.03 | 0.09 | |
| Return on Equity (ROE) | - | - | -862.92% | - | - | - | |
| Return on Assets (ROA) | -227.76% | -132.68% | -128.66% | -212.52% | -150.64% | -623.03% | |
| Return on Capital (ROIC) | - | - | -506.19% | - | - | - | |
| Earnings Yield | -101.34% | -63.63% | -38.52% | -72.97% | - | - | |
| FCF Yield | -60.21% | -50.63% | -32.41% | -91.48% | - | - | |
| Buyback Yield / Dilution | -29.96% | -93.96% | -65.38% | -71.00% | -1.75% | -9.62% | |
| Total Shareholder Return | -29.96% | -93.96% | -65.38% | -71.00% | -1.75% | -9.62% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.